|
Aug 6
|
U.S. Physical Therapy (USPH) Tops Q2 Earnings and Revenue Estimates
|
|
Aug 6
|
Curious about Elanco Animal Health (ELAN) Q2 Performance? Explore Wall Street Estimates for Key Metrics
|
|
Aug 6
|
What To Expect From Elanco’s (ELAN) Q2 Earnings
|
|
Aug 4
|
Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates
|
|
Jul 31
|
Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?
|
|
Jul 25
|
Why Elanco (ELAN) Stock Is Trading Up Today
|
|
Jul 24
|
Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs
|
|
Jul 24
|
ELAN vs. USPH: Which Stock Is the Better Value Option?
|
|
Jul 22
|
Are Medical Stocks Lagging Encompass Health (EHC) This Year?
|
|
Jul 21
|
Veterinary Dermatology - Company Evaluation Report 2025 | Zoetis, Elanco, and Boehringer Ingelheim Dominate with Global Reach, Innovative Portfolios, and Strategic Expansion
|
|
Jul 3
|
Elanco Animal Health Enters Into Licensing Agreement With Neurizon for Monepantel
|
|
Jul 2
|
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001
|
|
Jun 30
|
5 Revealing Analyst Questions From Elanco’s Q1 Earnings Call
|
|
Jun 26
|
Elanco Releases 2024 Impact Report and Introduces New Framework
|
|
Jun 26
|
General Mills upgraded, Trade Desk downgraded: Wall Street's top analyst calls
|
|
Jun 20
|
Shareholders in Elanco Animal Health (NYSE:ELAN) have lost 37%, as stock drops 3.5% this past week
|
|
May 28
|
How Elanco Plans on Winning in the Pet Wellness Boom
|
|
May 28
|
Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer
|
|
May 1
|
Astrana Health, Inc. (ASTH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
|
|
Apr 30
|
Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q1 Earnings Expected to Decline
|